Adirondack Trust CO Novartis Ag Transaction History
Adirondack Trust CO
- $259 Million
- Q3 2024
A detailed history of Adirondack Trust CO transactions in Novartis Ag stock. As of the latest transaction made, Adirondack Trust CO holds 289 shares of NVS stock, worth $30,136. This represents 0.01% of its overall portfolio holdings.
Number of Shares
289
Previous 289
-0.0%
Holding current value
$30,136
Previous $30,000
10.0%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding NVS
# of Institutions
1,435Shares Held
133MCall Options Held
1.12MPut Options Held
1.83M-
Dodge & Cox San Francisco, CA12.2MShares$1.27 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.25 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$844 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$728 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$602 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $224B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...